COVID-19 has created an ‘ecosystem’ of innovation in India: Kiran Mazumdar-Shaw

Mazumdar-Shaw is one of the key speakers at the 15th edition of the annual virtual summit on June 22 hosted by the USA India Chambers of Commerce.

The ongoing public health crisis has resulted in the creation of an “ecosystem” of innovation in India, Biocon chief Kiran Mazumdar-Shaw has said ahead of the annual India-U.S. bio-pharma summit in Boston next week. Mazumdar-Shaw, 68, is one of the key speakers at the 15th edition of the annual virtual summit on June 22 hosted by the USA India Chambers of Commerce. The other star-studded speakers include Dr. Albert Bourla, Chairman and CEO of Pfizer; Dr. Francis Collins, Director, National Institutes of Health; Dr. Janet Woodcock, Acting Commissioner, U.S. Food and Drug Administration; and Amitabh Kant, CEO of NITI Aayog. “The whole intent (of the more than a decade old annual India-U.S. bio pharma summit) is to catalyse an innovation ecosystem in India. I think, has actually created the ecosystem,” Mazumdar-Shaw told PTI in an interview.